Compare Stocks

→ Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
LXG LexaGene	C$0.11 -19.2%	C$0.11	C$0.07 ▼ C$0.31	C$14.77M	2.26	170,061 shs	2.14 million shs
ONC Oncolytics Biotech	C$1.46 +1.4%	C$1.44	C$1.20 ▼ C$4.49	C$110.11M	1.49	78,769 shs	34,851 shs
RYMDF Relay Medical	$0.02	$0.02	$0.13 ▼ $0.72	$4.37M	1.15	68,743 shs	N/A

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
LXG LexaGene	0.00%	0.00%	0.00%	0.00%	0.00%
ONC Oncolytics Biotech	+1.39%	0.00%	+5.80%	-11.52%	-8.75%
RYMDF Relay Medical	0.00%	-17.73%	+21.48%	+21.48%	-76.58%

Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (Ad)

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
LXG LexaGene	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ONC Oncolytics Biotech	0.6511 of 5 stars	3.5	0.0	0.0	0.0	1.3	0.0	0.0
RYMDF Relay Medical	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
LXG LexaGene	N/A	N/A	N/A	N/A
ONC Oncolytics Biotech	3.00	Buy	C$6.00	310.96% Upside
RYMDF Relay Medical	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest YGEN, ONC, GDR, RYMDF, and LXG Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
4/4/2024	ONC Oncolytics Biotech	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Outperform	C$3.00

(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
LXG LexaGene	C$110.93K	133.13	C$0.00 per share	21.25	C$0.01 per share	10.50
ONC Oncolytics Biotech	N/A	N/A	C$0.35 per share	4.22	C$0.37 per share	N/A
RYMDF Relay Medical	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
LXG LexaGene	-C$8.54M	-C$0.08	N/A	∞	N/A	N/A	-339.54%	-120.21%	N/A
ONC Oncolytics Biotech	-C$27.75M	-C$0.41	N/A	∞	N/A	N/A	-102.66%	-55.47%	5/3/2024 (Estimated)
RYMDF Relay Medical	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A

Latest YGEN, ONC, GDR, RYMDF, and LXG Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/7/2024	Q4 2023	ONC Oncolytics Biotech	-C$0.15	-C$0.05	+C$0.10	-C$0.05	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
LXG LexaGene	N/A	N/A	N/A	N/A	N/A
ONC Oncolytics Biotech	N/A	N/A	N/A	N/A	N/A
RYMDF Relay Medical	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
LXG LexaGene	138.01	1.39	1.13
ONC Oncolytics Biotech	1.54	9.01	8.86
RYMDF Relay Medical	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
LXG LexaGene	0.09%
ONC Oncolytics Biotech	6.98%
RYMDF Relay Medical	N/A

Insider Ownership

Company	Insider Ownership
LXG LexaGene	17.85%
ONC Oncolytics Biotech	6.24%
RYMDF Relay Medical	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
LXG LexaGene	41	140.64 million	N/A	Not Optionable
ONC Oncolytics Biotech	29	75.42 million	N/A	Not Optionable
RYMDF Relay Medical	N/A	241.20 million	N/A	Not Optionable

YGEN, ONC, GDR, RYMDF, and LXG Headlines

Source	Headline
	contact closure relay hackaday.com - March 14 at 8:51 PM
	Open Standard Relays Extend LoRa Networks rfidjournal.com - December 8 at 1:42 PM
	A Relay Calculator With DIY Neon Displays, Just Because hackaday.com - November 27 at 5:28 PM
	DARPA's POWER program partners to develop optical power beaming relays optics.org - September 12 at 7:12 PM
	World Athletics: Ukraine’s Mahuchikh wins gold, Dutch ‘steal’ women’s relay aljazeera.com - September 7 at 4:44 AM
	Relay FM Announces 10th Anniversary Event macstories.net - August 26 at 12:39 PM
	Best Medical Alert Necklaces Of 2023 forbes.com - August 10 at 11:27 PM
	A Relay-Based Pseudorandom Number Generator hackaday.com - July 8 at 5:42 PM
	Burrow Relay Review: We Tested Burrow's First Outdoor Sofa gearpatrol.com - July 8 at 7:36 AM
	Industry-first PXI/PXIe Microwave Relay Modules Capable of Switching 110 GHz Signals From Pickering Interfaces tmcnet.com - June 13 at 4:07 PM
	Paris Olympics torch relay will involve 10,000 runners news.yahoo.com - June 2 at 4:32 PM
	Relay Therapeutics Announces Full Dose Escalation Data for RLY-4008 technews.tmcnet.com - May 25 at 6:03 PM
	Because Building A Relay Computer Isn’t Hard Enough hackaday.com - May 13 at 8:03 AM
	Relay Computer Consumes Six Years And 4.5 Suitcases hackaday.com - May 10 at 2:12 PM
	A DIY 10-bit Relay Adder hackaday.com - May 2 at 9:45 AM
	Relay climbs 14% as Raymond James issues bullish view ahead of data readout msn.com - April 13 at 4:25 PM
	What is Medical Payments Coverage? How Does it Work? valuepenguin.com - April 12 at 12:41 AM
	WATCH: Texans’ 4x800 relay team sets national, meet record Saturday at 95th Clyde Littlefield Texas Relays kcbd.com - April 2 at 6:03 PM
	Surface Mount Reed Relays Market to Reach $658.9 Million, Globally, by 2031 at 6.9% CAGR: Allied Market Research tmcnet.com - March 23 at 8:16 PM
	MRMC to Launch New Sports, Studio Production Gear at 2023 NAB Show msn.com - March 15 at 12:18 PM
	Team Yukon takes bronze in relay at Canada Winter Games cbc.ca - March 1 at 11:15 PM
	RPCC to host Relay for Life with the American Cancer Society theadvocate.com - March 1 at 11:15 PM
	Goulburn Relay for Life finds new home at Cockbundoon, raises nearly $60,000 goulburnpost.com.au - November 5 at 10:15 PM
	Firefox Relay gives you a burner phone number to give out online mobilesyrup.com - October 25 at 3:56 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

Canoo, Inc. Bites the Dust: Mullen Automotive Is a Better Bet
April 2, 2024 9:15 AM
View Canoo, Inc. Bites the Dust: Mullen Automotive Is a Better Bet
Tesla Stock Drops on Weak Delivery Numbers and it May Fall More
April 2, 2024 11:25 AM
View Tesla Stock Drops on Weak Delivery Numbers and it May Fall More
Intel's Foundry Woes: Sell Signal or Silver Lining Ahead?
April 5, 2024 8:45 AM
View Intel's Foundry Woes: Sell Signal or Silver Lining Ahead?
Tesla Is the Analyst's Most Downgraded Stock: How Low Can It Go?
March 26, 2024 7:00 AM
View Tesla Is the Analyst's Most Downgraded Stock: How Low Can It Go?
Cannabis: One Stock to Play the Movement
April 8, 2024 8:38 AM
View Cannabis: One Stock to Play the Movement

All Headlines

Company Descriptions

LexaGene

CVE:LXG

LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The company was incorporated in 2007 and is headquartered in Beverly, Massachusetts.

Oncolytics Biotech

TSE:ONC

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. It has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep, as well as with Roche Holding AG. The company was incorporated in 1998 and is headquartered in Calgary, Canada.

Relay Medical

OTCMKTS:RYMDF

Relay Medical Corp. operates as a medical technology company, which engages in the development of novel medical devices for in vitro diagnostics and point-of-care testing. Its platform technologies include HemoPalm and Pharmatrac. The HemoPalm develops a POCT unit-use cartridge based blood analyzer with full enterprise capabilities. The Pharmatrac is an AI and data analytics driven personal medication management system that addresses the growing problem of non-adherence to treatment. The company was founded by James Samsoondar in 2005 and is headquartered in Toronto, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial